MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas
Human Cell · 2024
DOI: 10.1007/s13577-024-01037-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Cell, 2024. Verfasst von Divya Mohan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pathology, Neurosurgery, Neuroradiology and Radiation Oncology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 1100…. Hauptthemen laut MEDLINE: Ependymoma, Spinal Cord Neoplasms. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Pathology, Neurosurgery, Neuroradiology and Radiation Oncology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
- Departments of Pathology, Neurosurgery, Neuroradiology and Radiation Oncology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India. sharmamehar@yahoo.co.in.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Mohan, D., Nambirajan, A., Malik, R., Sharma, A., Suri, V., Kaur, K., Doddamani, R., Garg, A., Gupta, S., Mallick, S., & Sharma, M. C. (2024). MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas. Human Cell. https://doi.org/10.1007/s13577-024-01037-2
Vancouver
Mohan D, Nambirajan A, Malik R, Sharma A, Suri V, Kaur K, et al. MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas. Human Cell. 2024. doi:10.1007/s13577-024-01037-2
BibTeX
@article{Mohan2024,
author = {Mohan, Divya and Nambirajan, Aruna and Malik, Rafat and Sharma, Agrima and Suri, Vaishali and Kaur, Kavneet and Doddamani, Ramesh and Garg, Ajay and Gupta, Subhash and Mallick, Supriya and Sharma, Mehar Chand},
title = {MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas},
journal = {Human Cell},
year = {2024},
doi = {10.1007/s13577-024-01037-2}
}
EUVIMED